tiprankstipranks
Telo Genomics Corp (TSE:TELO)
:TELO
Canadian Market
TELO
Telo Genomics Corp
RESEARCH TOOLSreports

Telo Genomics Corp (TELO) Income Statement

21 Followers

Telo Genomics Corp Income Statement

Last quarter (Q2 2026), Telo Genomics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Telo Genomics Corp's net income was C$-526.62K. See Telo Genomics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 23Jun 22Sep 20Jun 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -14.45KC$ -39.54KC$ -33.11KC$ -62.23KC$ -64.72K
Operating Expenses
C$ 2.70MC$ 2.68MC$ 2.82MC$ 1.26MC$ 1.31M
Depreciation and Amortization
C$ 14.45KC$ 39.54KC$ 33.11KC$ 62.23KC$ 64.72K
EBITDA
C$ -2.69MC$ -2.67MC$ -2.78MC$ -1.01MC$ -1.15M
Operating Income
C$ -2.70MC$ -2.72MC$ -2.82MC$ -1.25MC$ -1.31M
Other Income/Expenses
C$ -16.37KC$ 5.39KC$ -5.21KC$ 182.61KC$ 69.16K
Pretax Income
C$ -2.72MC$ -2.71MC$ -2.82MC$ -1.07MC$ -1.24M
Net Income
C$ -2.72MC$ -2.71MC$ -2.82MC$ -1.07MC$ -1.24M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.04C$ -0.05C$ -0.02C$ -0.04
Diluted EPS
C$ -0.03C$ -0.04C$ -0.05C$ -0.02C$ -0.04
Weighted Average Shares Outstanding
 87.74M 71.38M 60.15M 46.89M 29.93M
Weighted Average Shares Outstanding (Diluted)
 87.74M 71.38M 60.15M 46.89M 29.93M
Currency in CAD

Telo Genomics Corp Earnings and Revenue History